跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
可必特 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Ipratropium Bromide Solution for Inhalation
Approved
化学药品
Compound Ipratropium Bromide Solution for Inhalation
Boehringer Ingelheim Scomm
🇨🇳 National Medical Products Administration
Approval Date
Feb 25, 2020
Approval ID
7MazXbMSmsu
Company
Boehringer Ingelheim Scomm
Type
化学药品
Approval Details
Approval Id
7MazXbMSmsu
Approval Number
H20150173
Generic Name
吸入用复方异丙托溴铵溶液
Generic Name En
Compound Ipratropium Bromide Solution for Inhalation
Trade Name
可必特
Brand Name
可必特
Drug Type
化学药品
Dosage Form
吸入用溶液剂
Strength
2.5ml:异丙托溴铵0.5mg(按C₂₀H₃₀BrNO₃计)与沙丁胺醇2.5mg(按C₁₃H₂₁NO₃计)
Reg Date
2020-02-25
Expired Date
2025-02-24
Company Name
Boehringer Ingelheim Scomm
Company Address
Avenue Arnaud Fraiteurlaan 15-23, B-1050 Brussels-Belgium
Production Company Name
LABORATOIRE UNITHER
Production Company Address
Espace Industriel Nord - 151 rue André Durouchez ?C CS 28028, 80084 Amiens Cedex 2 - France
Company Detail Path
/organization/boehringer-ingelheim-scomm
Production Company Detail Path
/organization/laboratoire-unither
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 25, 2020
Approval ID
7MazXbMSmsu
Type
化学药品
Back to NMPA Approvals